1. Abramowicz, M., Arneil, G. C., Barnett, H. L., Barron, B. A., Edelmann, C. M., Gordillo, G., Greifer, I., Hallmann, N., Kobayashi, O., and Tiddens, H. A., 1970, Controlled trial of azathioprine in children with nephrotic syndrome, Lancet 1: 959–961.
2. Arbeitsgemeinschaft für Pediatrisches Nephrologie, 1981, Alternate day prednisone is more effective than intermittent prednisone in frequently relapsing nephrotic syndrome, Eux. J. Pediatr. 135:229–237.
3. Balcke, P., Derfler, K., Stockenhuber, E., Kopsa, H., and Sunder-Plassmann, G., 1987, Cyclosporintherapie bei Minimal-change-Nephritis, Wien. Klin. Wschr. 99:242–245.
4. Berthoux, F. C., Guerin, C., Sabatier, J. C., Maret, J., and Genin, C., 1987, Cyclosporin A (CsA) treatment of steroid-resistant and persistent nephrotic syndrome in primary membranous giomerulonephritis, Nephrol Dial. Transplant. 2:412.
5. Black, D. A. K., Rose, G., and Brewer, D. B., 1970, Controlled trial of prednisone in adult patients with nephrotic syndrome, Br. Med. J. 3:421–426.